Table 1. Patient characteristics.
| No (%) | |
|---|---|
| No. of patients | 40 |
| Age | |
| Median | 72 |
| Range | 55–83 |
| ECOG performance status | |
| 0 | 19 (47.5) |
| 1 | 21 (52.5) |
| Locally advanced disease | 3 (8) |
| Metastatic disease | 37 (92) |
| Sites of disease | |
| Prostate | 27 (68) |
| Bone | 27 (68) |
| Nodes | 17 (43) |
| Liver | 3 (8) |
| No. of involved organs | |
| 1 | 11 (28) |
| >1 | 29 (73) |
| Prior treatment | |
| Hormone therapy | 40 (100) |
| Radiotherapy | 13 (33) |
| Prostatectomy | 13 (33) |
| Serum PSA | |
| Median (ng ml−1) | 58 |
| Range | 12–912 |
| Gleason score | |
| ⩽7 | 13 (32.5) |
| 8–10 | 18 (45) |
| Not available | 9 (22.5) |
| Pain | |
| VAS scale ⩾1 | 11 (27.5) |
Abbreviation: ECOG=Eastern Cooperative Oncology Group.